Pipeline

At Somaxon Pharmaceuticals, we are focused on providing products for medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction. Since the launch of Silenor^® in late 2010, we have built a commercial infrastructure that includes a dedicated sales force.

Currently we are focused on leveraging this commercial infrastructure by actively pursuing late-stage product candidates and approved products to add to our product portfolio, which currently is focused in the central nervous system therapeutic area.

To learn more about partnering with Somaxon, please visit the Partners section of this web site.